The lymphocytes from eight patients with active visceral leishmaniasis (VL), a disease associated with marked immunologic dysfunction, were examined for ability to produce interleukin 2 (IL-2) and gamma interferon during in vitro cultivation. It was found that both IL-2 and gamma interferon production, in response to leishmania antigen, was absent during the active disease, but was restored after successful chemotherapy. Untreated VL patients produced IL-2 and gamma interferon when stimulated with phytohemagglutinin (PHA). Six patients with either active cutaneous or mucosal leishmaniasis, a disease not associated with immunosuppression, showed high levels of gamma interferon in response to leishmania antigen and PHA. Since IL-2 and gamma interferon have been shown to have important roles in the immune response and in the killing of leishmania, their absence may represent a key defect in the immune response in VL.
Introduction
Since early observations of the protozoan disease visceral leishmaniasis (VL),' it has been clear that immunologic dysfunction is an important aspect of the illness. The immunologic defects that have been described include the following: (a) absence of antigen-specific intradermal skin test responses (1, 2); (b) depressed lymphocyte transformation to leishmania antigen (3) ; (c) presence of serum suppressor factors (4); (d) presence of circulating immune complexes and polyclonal hypergammaglobulinemia (5); and (e) increased susceptibility to various infections (6) . In order to focus more specifically on the immunologic defects in leishmaniasis and to determine the possible mechanisms of pathogenesis of Leishmania donovani infection, we examined the ability of lymphocytes from patients with active VL to produce gamma interferon and interleukin 2 (IL-2). In addition, the lymphocyte response to leishmania antigen and the numbers of T cell subsets were determined.
1. Abbreviations used in this paper: AIDS, acquired immune deficiency syndrome; Con A, concanavalin A; IL-2, interleukin 2; VL, visceral leishmaniasis.
Patients were seen in either the Federal University Hospital in Salvador, Bahia, Brazil, or in an area (Jacobina, Bahia, Brazil) endemic for VL (7) . They presented with characteristic signs and symptoms ofactive VL, including fever, hepatosplenomegaly, anemia, leukopenia, and hyperglobulinemia. The Ag of leishmania antigen. After 24 h the supernatants were harvested, filtered (Millipore, 0.45 Aim), and stored at -20°C. IL-2 was measured using IL-2-dependent CTLL-2 cells (9) . These cells were incubated with different dilutions of supernatant and the uptake of [3H1thymidine was determined after 24 h of incubation. The degree of CTLL-2 cell stimulation produced by supernatants was compared with that obtained using an IL-2 standard generated by concanavalin-A (Con A)-stimulated FS6 virus in WISH cells (11) . Antiviral activity was measured against a laboratory gamma interferon standard and is expressed as international units per milliliter (12) .
Lymphocyte subpopulation. To determine the percentage of T cells and T cell subsets, the mononuclear cells obtained from peripheral blood were depleted of macrophages by incubation of 8 X 106 cells in 6 ml of RPMI, supplemented with 20% fetal calfserum at 37°C for 1 h on plastic. T cells were identified by the ability of these cells to bind three or more sheep erythrocytes (13). OKT' and OKT' cells were identified by indirect immunofluorescence using specific monoclonal antibodies (Anti-OKT4 and anti-OKT8) (Ortho Diagnostic Systems, Inc., Raritan, NJ) and a fluorescinated goat anti-mouse immunoglobulin (14) .
Results Table I shows lymphocyte transformation responses to leishmania antigen and gamma interferon production by lymphocytes from eight patients with active VL, six patients with either mucosal or cutaneous leishmaniasis, and four healthy uninfected controls. As noted previously (3) , proliferation responses to leishmania antigen during active visceral disease are markedly suppressed and do not exceed the responses of cells cultured without antigen or that of cells from healthy controls cultured with antigen. In contrast, the patients with mucocutaneous disease showed a good proliferative response to leishmania antigen (15) . Gamma interferon levels were significantly lower in supernatants of lymphocytes from eight VL patients and equal to levels from unstimulated cells or cells from uninfected controls. Mucocutaneous patients showed high gamma interferon production under identical conditions. No significant differences were found in gamma interferon levels produced by phytohemagglutinin-stimulated cells in the three groups.
In addition, IL-2 levels in antigen-stimulated cells from the four active VL patients tested were found to be significantly lower (433±370 cpm), when compared with levels obtained from antigen-stimulated cells from mucocutaneous leishmaniasis patients (9,465±8,174). Phytohemagglutinin-stimulated cells from individuals in the three groups did not differ significantly in IL-2 production (VL, 9,523±1,071; mucocutaneous leishmaniasis, 18,488±12,926; healthy subjects, 9,380±8,325). The number of OKT' and OKT' cells was determined in the peripheral blood of four VL patients. One patient had a decreased number of T cells (less than the mean±2 SD of controls, 2,310±543 mm3). The number of OKT' cells ranged from 458 to 1,746 mm3, and OKT' cells ranged from 427 to 1,100 mm3. The OKT4/OKT8 ratio was 1.5±0.8, which is comparable with 2.3±0.4 in controls (four healthy subjects).
To evaluate the change in gamma interferon and IL-2 levels associated with recovery from active VL, we studied three patients both before and after antimony therapy. Table II shows the data obtained from these patients. Proliferative responses were absent before therapy, but after therapy a mean proliferation response of 13,831 cpm was observed. Gamma interferon levels also increased from 11±2 U/ml to a mean of 172 U/ml after treatment. IL-2 was present in significant amounts in 24-h lymphocyte supernatants only after therapy.
Discussion
It is apparent that an important aspect of VL is a decrease in the ability of lymphocytes to respond to leishmania antigen by proliferation (3, 16, 17) or by lymphokine production. There is not a generalized suppression oflymphocyte function since cells from VL patients responded normally in proliferation and in lymphokine production when stimulated with a lymphocyte mitogen. Recovery from active disease was associated with a lymphocyte response to leishmania antigen and production of lymphokines.
Lymphocytes from patients with active VL did not produce either IL-2 or gamma interferon when stimulated with leishmania antigen. IL-2 is important in mediating several Ilymphocyte functions (18, 19) and gamma interferon has been demonstrated to be the lymphokine that activates macrophages to kill leishmania intracellularly (20) . The finding that lymphocytes from patients with active VL are unable to produce these lymphokines in response to specific antigen allows us to focus on what may be the major site of immune dysfunction during this disease.
VL is a complex disease associated with many features that could cause immunosuppression. For example, immune complexes are present (5, 21) and these have been associated with immune dysfunction in other diseases. We have found that sera from patients with active VL suppress mitogen-induced lymphocyte proliferation of normal cells (4) . Further, there is a depletion of lymphocytes in T cell-dependent areas of the spleen and lymph nodes of VL patients (22) . In spite of these recognized abnormalities, it remains unknown why there is antigen-specific unresponsiveness, manifested by the inability of lymphocytes to proliferate and produce lymphokine during active VL. (23, 24) . However, the mechanism of the altered production of lymphokines in AIDS and VL is probably different. For example, the inability to produce lymphokine is antigen specific in VL, and OKTt numbers are preserved during leishmaniasis, while nonspecific lymphocyte suppression and decreased numbers of OKT' cells occur in AIDS. Low gamma interferon production has also been reported in lepromatous leprosy (25). This decreased lymphokine production appears not to be antigen specific since low gamma interferon levels were observed in Con A-stimulated cultures, it was not restored by therapy, and an increase in tissue OKT '8 cells was recorded. Whether these results, which differ from those observed in the patients with VL reported here, represent differences in technique of study or differences between the two diseases needs to be determined. In one patient with early cutaneous leishmaniasis, both proliferation of lymphocytes and gamma interferon production were low, and restoration occurred either with natural progression of the immune response or drug therapy (26) .
The pathogenesis of VL is not understood. It is clear that active VL is but one part of the disease spectrum of L. donovani infection since most of the infected subjects do not develop disease (7, 27) . In an area endemic for VL, we have also observed that early in the infection some patients have the ability to respond to leishmania antigen by lymphocyte blastogenesis and intradermal skin test, and some do not (personal observation). The mechanisms that determine progression ofthe infection are unknown. It is clear that a depressed cell-mediated immune response is a hallmark of the disease, and it is possible that susceptibility to the development of clinical VL is related to an inability to generate IL-2 and gamma interferon to leishmania antigens during the infection.
